Translocation (3;21)(q26;q22) in de novo acute myelogenous leukemia

被引：6
|
作者：
Motomura, S
Fujisawa, S
Tsunooka, S
Fujimaki, K
Harano, H
Mohri, H
Okubo, T
Fujita, H
Maruta, A
Kodama, F
机构：
[1] YOKOHAMA CITY UNIV,SCH MED,DEPT INTERNAL MED 1,YOKOHAMA,KANAGAWA 232,JAPAN
[2] KANAGAWA CANC CTR,DEPT HEMATOL & CHEMOTHERAPY,KANAGAWA,JAPAN
来源：
LEUKEMIA | 1997年 / 11卷 / 01期
关键词：
D O I：
10.1038/sj.leu.2400533
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：172 / 173
页数：2
相关论文
共 50 条
  • [31] DEFINING T(15;17)(Q22;21) TRANSLOCATION MECHANISM IN THERAPY RELATED AND DE NOVO ACUTE PROMYELOCYTIC LEUKEMIA
    Hasan, S. K.
    Ottone, T.
    Schlenk, R.
    Mitra, M. E.
    Ammatuna, E.
    Bernasconi, P.
    Di Raimondo, F.
    Stanghellini, M. T. Lupo
    Marco, P.
    Mays, A. N.
    Grimwade, D.
    Dohner, H.
    Lo-Coco, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 331 - 331
  • [32] Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26)
    E. Reiter
    H. Greinix
    W. Rabitsch
    F. Keil
    I. Schwarzinger
    U. Jaeger
    K. Lechner
    N. Worel
    B. Streubel
    C. Fonatsch
    G. Mitterbauer
    P. Kalhs
    Annals of Hematology, 2000, 79 : 374 - 377
  • [33] NEW CASE OF T(3 17)(Q26 Q22) AS AN ADDITIONAL CHANGE IN A PHILADELPHIA-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA IN ACCELERATION
    MUGNERET, F
    SOLARY, E
    FAVRE, B
    CAILLOT, D
    SIDANER, I
    GUY, H
    CANCER GENETICS AND CYTOGENETICS, 1992, 60 (01) : 90 - 92
  • [34] CHARACTERIZATION OF THE RARE TRANSLOCATION T(3;10)(Q26;Q21) IN AN ACUTE MYELOID LEUKEMIA PATIENT
    Jancuskova, T.
    Plachy, R.
    Stika, J.
    Hardekopf, D. W.
    Zejskova, L.
    Praulich, I.
    Kreuzer, K. A.
    Kosyakova, N.
    Liehr, T.
    Pekova, S.
    HAEMATOLOGICA, 2014, 99 : 283 - 284
  • [35] Putative BCHE gene involvement in a reciprocal translocation t(3;5)(q26;q22) in an unusual myelogenous disorder with myeloproliferative and dysplastic features
    Streubel, B
    Füreder, W
    Jordan, H
    Walchshofer, S
    Wimazal, F
    Jäger, U
    Geissler, K
    Schwartz, L
    Chott, A
    Lechner, K
    Valent, P
    Fonatsch, C
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 87 - 87
  • [36] Reciprocal translocation (3;5)(q26;q22) and possible BCHE gene involvement in an unusual myelogenous disorder with bath myeloproliferative and dysplastic features
    Füreder, W
    Streubel, B
    Jordan, JH
    Walchshofer, S
    Wimazal, F
    Jäger, U
    Geissler, K
    Schwartz, LB
    Chott, A
    Lechner, K
    Valent, P
    Fonatsch, C
    CANCER GENETICS AND CYTOGENETICS, 2000, 121 (02) : 133 - 138
  • [37] VASCULAR ENDOTHELIAL GROWTH FACTOR-C AND ITS RECEPTOR TYPE-3 WERE EXPRESSED IN TWO CASES OF ACUTE MYELOGENOUS LEUKEMIA WITH T(3;21)(Q26;Q22)
    Tashiro, H.
    Shirasaki, R.
    Oka, Y.
    Akiyama, N.
    Kawasugi, K.
    Shirafuji, Ni
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 504 - 504
  • [38] t(3;21)(q26;q22) in myeloid leukemia - An aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy
    Yin, CC
    Cortes, J
    Barkoh, B
    Hayes, K
    Kantarjian, H
    Jones, D
    CANCER, 2006, 106 (08) : 1730 - 1738
  • [39] Translocation(8;20;21)(q22;q13;q22) in acute myeloblastic leukemia with maturation: A variant form of t(8;21)
    Wong, KF
    Kwong, YL
    So, CC
    CANCER GENETICS AND CYTOGENETICS, 1998, 101 (01) : 39 - 41
  • [40] Duplication of der(21) t(8;21)(q22;q22) in Acute Myeloid Leukemia
    Yamamoto, Katsuya
    Okamura, Atsuo
    Matsuoka, Hiroshi
    Minami, Hironobu
    INTERNAL MEDICINE, 2014, 53 (01) : 73 - 74
12345